An experimental drug that can virtually halt the deadly spread of breast cancer has been tested by scientists.
Researchers are now working with a biotechnology company to prepare the compound for patient trials.
The new research builds on previous studies of a gene called Bc13 that appears to play a critical role in the spread of breast cancer.
Scientists at Cardiff University conducted computer simulations to work out how Bc13 functioned and then blocked it.
In tests on mice, the researchers first deleted the gene and then explored ways of inhibiting it with a drug.They found the right candidate compound by screening a library of chemicals until one was found that could target Bc13.
When mice with metastatic breast cancer were treated with the compound, the spread of tumours to the lungs and other parts of the body was dramatically reduced.
More top news
Jeremy Corbyn has come under fire in a fresh row over Israel after he appeared to compare the Israeli state to jihadi terrorists.
Thousands of soldiers who died in the Battle of the Somme will be remembered today at commemoration events across the UK and France.
Soliciting of clients by sex workers should no longer be a crime, according to new recommendations made by Home Affairs Select committee.